4 Billingai Close Palm Cove QLD 4879

Current asking price $1.4–$1.5m | Built 2014, renovated | Positioned in Argentea enclave | Pool and solar equipped This four-bedroom house on a 661-square-metre block in Palm Cove’s established Argentea neighbourhood appeals to buyers seeking a renovated coastal residence with modern amenities and proximity to the esplanade lifestyle without premium beachfront pricing. The property was constructed in 2014 and has undergone recent renovation to contemporary standards, positioning it as a move-in-ready option rather than a project home. The land holding of 661 square metres is substantial for the Palm Cove market, offering genuine usable space with a fully fenced yard, courtyard, and in-ground pool—features that justify its appeal to families and retirees seeking outdoor living capability beyond typical unit-scale offerings. The inclusion of solar panels and modern infrastructure reflects current buyer expectations around running costs and sustainability, while reliable NBN fibre and 5G coverage address practical connectivity needs. Argentea remains one of Palm Cove’s more tightly held addresses, suggesting established demand and controlled supply. The property’s asking range of $1.4 to $1.5 million represents a significant appreciation from its 2014 purchase price of approximately $692,500, reflecting both broader Far North Queensland market growth and the value added through renovation and land retention. Properties at this price level in Palm Cove typically attract interstate relocators, retirees seeking tropical downsizing with substance, and investors targeting the stable rental market that coastal Queensland addresses support. The absence of bushfire, flood, or heritage overlays removes regulatory friction commonly encountered in northern coastal properties, which enhances both insurability and future development optionality. Market positioning suggests this holding will appeal to a defined buyer cohort with adequate capital and coastal lifestyle priority, though the current listing status (withdrawn in 2025, relisted March 2026) indicates either market recalibration or strategic repositioning rather than distressed circumstance.